HIGHLIGHTS
- who: Richard Lindqvist and collaborators from the Department of Clinical Microbiology, Umeu00e5 University, Umeu00e5, Universitetsparken, Copenhagen, Denmark have published the paper: A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses, in the Journal: Viruses 2022, 2202 of /2022/
- what: The authors show that a highly potent and metabolically stable peptide inhibitor that binds to the PDZ1 domain of syntenin inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking the endosomal entry of the virus. The authors demonstrate the importance of syntenin for infection of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.